Glipensupreme Plus Tablet (Pitavastatin Calcium, Fenofibrate)

Adult dose

As a recommended dose, take one tablet daily regardless of meals.

This medication contains two ingredients, Pitavastatin Calcium and Fenofibrate, which are used to control blood lipid levels. Caution is advised as muscle-related symptoms such as myalgia, muscle weakness, and muscle cramps may occur during treatment with this drug. Particularly, there is a risk of severe muscle damage known as rhabdomyolysis, which requires immediate consultation with a physician if such symptoms arise. Patients over 65 years old, those with impaired kidney function, uncontrolled hypothyroidism, and individuals with alcohol addiction should undergo blood tests before taking this medication to assess the risk of muscle damage. Using this medication along with other lipid-lowering agents or specific drugs may increase the risk of muscle toxicity; thus, it is important to inform your doctor of any medications you are currently taking. This medication may affect liver function, so patients with liver disease or elevated liver enzymes should have regular check-ups and discontinue if liver function worsens. Additionally, this drug may influence kidney function, requiring special caution in patients with reduced kidney function and regular kidney function tests during treatment. Women who are pregnant, possibly pregnant, or nursing should not take this medication, and it is not administered to children due to safety concerns. Rare side effects such as skin rash, itching, headache, dizziness, dyspepsia, and various mild liver function abnormalities may occur, so immediate consultation with healthcare professionals is advised if any unusual symptoms present. During treatment, regular testing of blood lipid levels as well as liver and kidney function should be conducted, and treatment should be halted if no therapeutic effect is observed. This medication should be temporarily discontinued if there is a planned surgery or significant health condition change. This drug has minimal impact on the ability to drive or operate machinery, but caution is warranted due to the possibility of dizziness. There is no specific antidote for overdose; hence, appropriate treatment should be provided according to the symptoms. Lastly, this medication should be stored out of the reach of children and kept in its original container.

Serious side effects

Hives, angioedema, severe allergic reactions, severe skin reactions accompanied by fever, rash, blisters, mucosal pain in the mouth/eyes (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), difficulty breathing or shortness of breath, asthma attacks, respiratory difficulties associated with coughing and fever, jaundice (yellowing of the skin or eyes), profound lethargy, sudden and severe headaches, thunderclap headache.

Mild side effects

Nasal pharyngitis, upper respiratory infections, dizziness, chronic gastritis, erosive gastritis, nausea, headache, thrombocytopenia, increased hematuria, palpitations, fatigue, skin pain, burning sensations, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, increased uric acid levels, elevated serum potassium and phosphorus, taste disturbances, discolored urine, lethargy, hair loss, rash, itching, and elevated blood test values indicating mild liver dysfunction, muscle pain, muscle cramps, myositis.

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication for an extended period.

Appearance

Pink oval film-coated tablets

Package unit

30 tablets/bottle